<?xml version="1.0" encoding="UTF-8"?>
<ref id="ddr21709-bib-0162">
 <mixed-citation publication-type="journal" id="ddr21709-cit-0162">
  <string-name>
   <surname>Subissi</surname>, 
   <given-names>L.</given-names>
  </string-name>, 
  <string-name>
   <surname>Imbert</surname>, 
   <given-names>I.</given-names>
  </string-name>, 
  <string-name>
   <surname>Ferron</surname>, 
   <given-names>F.</given-names>
  </string-name>, 
  <string-name>
   <surname>Collet</surname>, 
   <given-names>A.</given-names>
  </string-name>, 
  <string-name>
   <surname>Coutard</surname>, 
   <given-names>B.</given-names>
  </string-name>, 
  <string-name>
   <surname>Decroly</surname>, 
   <given-names>E.</given-names>
  </string-name>, &amp; 
  <string-name>
   <surname>Canard</surname>, 
   <given-names>B.</given-names>
  </string-name> (
  <year>2014</year>). 
  <article-title>SARS‐CoV ORF1b‐encoded nonstructural proteins 12‐16: Replicative enzymes as antiviral targets</article-title>. 
  <source xml:lang="en">Antiviral Research</source>, 
  <volume>101</volume>, 
  <fpage>122</fpage>–
  <lpage>130</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2013.11.006</pub-id>
  <pub-id pub-id-type="pmid">24269475</pub-id>
 </mixed-citation>
</ref>
